189 related articles for article (PubMed ID: 35464684)
1. Vogt-Koyanagi-Harada disease following influenza vaccination.
Murtaza F; Pereira A; Mandelcorn MS; Kaplan AJ
Am J Ophthalmol Case Rep; 2022 Jun; 26():101516. PubMed ID: 35464684
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
3. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
4. Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.
Hosseini SM; Dourandish M; Mazouchi M
J Ophthalmic Vis Res; 2020; 15(1):99-103. PubMed ID: 32128086
[TBL] [Abstract][Full Text] [Related]
5. Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache.
A V P; Kumar J S A; K N N; Rao S; Shetty S
J Clin Diagn Res; 2014 Apr; 8(4):VD06-VD07. PubMed ID: 24959501
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis.
Park JG; Callaway NF; Ludwig CA; Mahajan VB
Am J Ophthalmol Case Rep; 2020 Sep; 19():100859. PubMed ID: 32793845
[TBL] [Abstract][Full Text] [Related]
7. Incomplete Vogt-Koyanagi-Harada in a 14-year-Old African American female with bilateral disc edema.
Ataei Y; Samara WA; Felton WL; Brar VS
Am J Ophthalmol Case Rep; 2021 Jun; 22():101114. PubMed ID: 34013096
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.
Nagai R; Yamamoto A; Yoshida A; Mikawa A
Case Rep Ophthalmol Med; 2023; 2023():9565205. PubMed ID: 36818144
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada Disease Associated with Hepatitis B Vaccination.
Sood AB; O'Keefe G; Bui D; Jain N
Ocul Immunol Inflamm; 2019; 27(4):524-527. PubMed ID: 29953303
[No Abstract] [Full Text] [Related]
12. Ocular syphilis mimicking Vogt-Koyanagi-Harada disease.
Lin YC; Lo KJ; Chen SJ; Hwang DK
Taiwan J Ophthalmol; 2019; 9(4):271-275. PubMed ID: 31942434
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada
Campos WR; Cenachi SPF; Soares MS; Gonçalves PF; Vasconcelos-Santos DV
Ocul Immunol Inflamm; 2021 Jan; 29(1):124-127. PubMed ID: 31603703
[No Abstract] [Full Text] [Related]
14. COVID-19 Vaccine-Related Vogt-Koyanagi-Harada Disease Complicated by Central Serous Chorioretinopathy during Treatment Course: Case Report and Literature Review.
Han R; Xu G; Ding X
Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366301
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada disease in a patient with extreme anisometropia.
Maehira M; Oshiro A; Imanaga N; Yamauchi Y; Koizumi H
Am J Ophthalmol Case Rep; 2023 Dec; 32():101929. PubMed ID: 37771387
[TBL] [Abstract][Full Text] [Related]
16. Vogt Koyanagi Harada disease following a recent COVID-19 infection.
Anthony E; Rajamani A; Baskaran P; Rajendran A
Indian J Ophthalmol; 2022 Feb; 70(2):670-672. PubMed ID: 35086262
[TBL] [Abstract][Full Text] [Related]
17. Reflectance adaptive optics findings in a patient with Vogt-Koyanagi-Harada disease.
Pham AT; Onghanseng N; Halim MS; Ormaechea MS; Hassan M; Akhavanrezayat A; Uludag G; Tran AN; Razeen MM; Sredar N; Dubra A; Nguyen QD
Am J Ophthalmol Case Rep; 2022 Sep; 27():101660. PubMed ID: 35880207
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study.
Muto T; Sakamoto M; Imaizumi S; Kamoi K
J Int Med Res; 2024 Jan; 52(1):3000605231221081. PubMed ID: 38170955
[TBL] [Abstract][Full Text] [Related]
19. Headache as an initial manifestation of Vogt-Koyanagi-Harada disease.
Khairallah AS
Saudi J Ophthalmol; 2014 Jul; 28(3):239-42. PubMed ID: 25278805
[TBL] [Abstract][Full Text] [Related]
20. Wide-field fluorescein and indocyanine green angiography findings in the eyes with Vogt-Koyanagi-Harada disease.
Kurobe R; Hirano Y; Niwa N; Sugitani K; Yasukawa T; Yoshida M; Ogura Y
J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):16. PubMed ID: 28695542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
